This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Consiglio Nazionale Delle Richerche, Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione-Istituto Dermopatico Dell'immacolata, Università Degli Studi Di Roma "La Sapienza". Active years: 2012.
Company Filing History:
1 out of 31 
1 out of 2 
1 out of 63 
Years Active: 2012
Title: Veronica Morea: Innovator in Proangiogenic Peptide Research
Introduction
Veronica Morea is a distinguished inventor based in Rome, Italy. She has made significant contributions to the field of pharmacology, particularly in the development of peptides with proangiogenic activity. Her innovative work has the potential to impact therapeutic strategies for various medical conditions.
Latest Patents
Veronica holds a patent for a peptide derived from vascular endothelial growth factor receptor-1 binding integrin α5β1, which exhibits proangiogenic activity. The patent describes a sequence peptide isolated in the domain II type-immunoglobulin (Type-Ig) of the Vascular Endothelial Growth Factor receptor 1 (VEGF-1). This peptide is usable for the preparation of pharmacological agents that promote angiogenesis, which is crucial for tissue repair and regeneration.
Career Highlights
Throughout her career, Veronica has worked with notable organizations, including the Italian Province of the Congregation of the Sons of the Immaculate Conception and the National Research Council of Italy. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Veronica has collaborated with esteemed colleagues such as Cristina Maria Failla and Angela Orecchia. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Veronica Morea is a pioneering inventor whose work in proangiogenic peptides holds promise for future medical advancements. Her contributions to pharmacology and her collaborations with other researchers underscore her commitment to innovation in the field.